SNDL (SNDL) reported $677M in revenue for fiscal 2025, +0.8% year on year. That ranks #2027 by revenue among 2853 SEC filers and #193 in Healthcare. It posted a net loss of −$11.3M for the same year. Revenue has grown 55.5% a year on average since 2019 ($47.9M then). The fiscal 2025 balance sheet shows $976M in total assets, $184M in cash and $23.6M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueC$946M | $677M | +0.8% | FY20252025-12-31 |
| Gross profitC$259M | $185M | +5.5% | FY20252025-12-31 |
| Operating income−C$6.3M | −$4.5M | +$71.3M | FY20252025-12-31 |
| Net income−C$15.8M | −$11.3M | +$57.9M | FY20252025-12-31 |
| Operating cash flowC$70.9M | $50.8M | +26.6% | FY20252025-12-31 |
| Capital expenditureC$12.8M | $9.2M | +45.7% | FY20252025-12-31 |
| Total assetsC$1.3B | $976M | +4.0% | FY20252025-12-31 |
| Shareholders' equityC$1.1B | $804M | +2.1% | FY20252025-12-31 |
| CashC$252M | $184M | +21.4% | FY20252025-12-31 |
| Long-term debtC$32.2M | $23.6M | — | FY20182018-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Figures are reported under IFRS in CAD and converted to US dollars at ECB reference rates — fiscal 2025 average 1.397 CAD/$ for income items, year-end 1.369 CAD/$ for balance-sheet items.
Profile
- Legal name
- SNDL Inc.
- Ticker
- SNDL
- Exchange
- Nasdaq
- SIC classification
- Medicinal Chemicals & Botanical Products (2833)
- Fiscal year end
- 12-31
- CIK
- 0001766600
Filings
- 40-FMar 12, 2026Open filing →
- 40-FMar 18, 2025Open filing →
- 40-FMar 21, 2024Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Supernus PharmaceuticalsSUPN | $719M | −$38.6M |
| Avanos MedicalAVNS | $701M | −$72.9M |
| Kiniksa Pharmaceuticals InternationalKNSA | $678M | $59.0M |
| SNDLSNDL | $677M | −$11.3M |
| Ultragenyx PharmaceuticalRARE | $673M | −$575M |
| Cresco LabsCRLBF | $656M | −$135M |
| NovocureNVCR | $655M | −$136M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=SNDL — Key figures |url=https://companiesranked.com/en/company/sndl |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). SNDL — Key figures. CompaniesRanked. https://companiesranked.com/en/company/sndlBibTeX
@misc{companiesranked-en-company-sndl-2026,
author = {{CompaniesRanked}},
title = {{SNDL — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/sndl}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 40-F · 0001193125-26-102524 · March 12, 2026
{{cite web |title=SNDL — Key figures — 40-F (0001193125-26-102524) |url=https://www.sec.gov/Archives/edgar/data/1766600/000119312526102524/sndl-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-12}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.